GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B8763 ML339 -
B8782 MS15203Summary: A selective GPR171 agonist for increasing food intake and body weight -
B8904 PiribedilSummary: A dopamine D2/D3 agonist and α2 receptor antagonist for Parkinson's disease -
N1114 Puerarin -
N1393 3-Hydroxy-4-methoxycinnamic acid -
N1401 Ginsenoside Ro -
N1442 Theophylline -
N1528 Sec-O-Glucosylhamaudol -
N1573 TheobromineSummary: Xanthine alkaloid -
N1578 NuciferineSummary: Alkaloid found in Nymphaea caerulea and Nelumbo nucifera

